Kari Anglin, NP
Family · West Bloomfield, MINPI 1649712183
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.9%. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $94.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- MDD US Operations, LLC$3K
- AbbVie$2K
- Acadia Pharmaceuticals Inc$1K
- Boston Scientific$765
- Teva Pharmaceuticals USA, Inc.$754
- plus $2K from 10 others
What the payments were for
- Consulting fees$2,19017%
- Travel & lodging$3,69628%
- Food & beverage$6,37949%
- Education$7286%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 31 | $3,099 |
| MDD US Operations, LLC | 16 | $2,842 |
| AbbVie | 9 | $2,048 |
| Acadia Pharmaceuticals Inc | 15 | $1,004 |
| Boston Scientific | 7 | $765 |
| Teva Pharmaceuticals USA, Inc. | 19 | $754 |
| Kyowa Kirin, Inc. | 6 | $526 |
| Supernus Pharmaceuticals, Inc. | 17 | $467 |
| AstraZeneca | 3 | $385 |
| Abbott | 3 | $347 |
| Amneal Pharmaceuticals LLC | 3 | $340 |
| Jazz Pharmaceuticals Inc. | 1 | $122 |
| Revance Therapeutics, Inc. | 1 | $116 |
| Sunovion Pharmaceuticals Inc. | 1 | $72 |
| Acorda Therapeutics, Inc | 4 | $70 |
| Neurocrine Biosciences, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,993 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 146 | $751,753 |
| ApokynApomorphine Hcl | 22 | $498,267 |
| RytaryCarbidopa/Levodopa | 150 | $305,535 |
| IngrezzaValbenazine Tosylate | 30 | $275,279 |
| GocovriAmantadine Hcl | 73 | $190,485 |
| AustedoDeutetrabenazine | 21 | $172,005 |
| InbrijaLevodopa | 27 | $101,499 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 1,145 | $82,638 |
| Droxidopa | 39 | $64,089 |
| NourianzIstradefylline | 17 | $37,259 |
| NeuproRotigotine | 29 | $36,583 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 249 | $25,591 |
| Pramipexole ErPramipexole Di-Hcl | 36 | $23,401 |
| Ropinirole ErRopinirole Hcl | 92 | $15,825 |
| AmantadineAmantadine Hcl | 217 | $12,970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $1,004 | $751,753146 claims |
| Amneal Pharmaceuticals LLCRytary | $340 | $305,535150 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $36 | $275,27930 claims |
| MDD US Operations, LLCGocovri | $2,842 | $190,48573 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $754 | $172,00521 claims |
| Acorda Therapeutics, IncInbrija | $70 | $101,49927 claims |
| Kyowa Kirin, Inc.Nourianz | $526 | $37,25917 claims |
| AbbVieLinzess | $2,048 | $7,56211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in West Bloomfield
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.